Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 132

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-21-2_002

تاریخ نمایه سازی: 27 مهر 1400

Abstract:

Objective(s): Production of effective tuberculosis (TB) vaccine is necessity. However, the development of new subunit vaccines is faced with concerns about their weak immunogenicity. To overcome such problems, polymers-based vaccine delivery systems have been proposed to be used via various routes. The purpose of this study was to determine the potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against TB. Materials and Methods: PubMed, Scopus, Science-Direct, and the ISI web of knowledge databases were searched for related keywords. A total of ۴۲۰ articles, written up to June ۲۵, ۲۰۱۶, were collected on the potential of polymeric particles as TB vaccine delivery systems after parenteral and non-parenteral immunization. Thirty-one relevant articles were selected by applying inclusion and exclusion criteria. Results: It was shown that the immunogenicity of TB vaccines had been improved by using biodegradable and non-biodegradable synthetic polymers as well as natural polymers and they are better able to enhance the humoral and cellular immune responses, compared to TB vaccines alone. The present study revealed that various polymeric particles, after M. tuberculosis challenge in animal models, provide long-lasting protection against TB. PLGA (poly (lactide-co-glycolide)) and chitosan polymers were widely used as TB vaccine delivery systems/adjuvants. Conclusion: It seems that PLGA and chitosan polymers are well-suited particles for the parenteral and non-parenteral administration of TB vaccines, respectively. Non-biodegradable synthetic polymers in comparison with biodegradable synthetic and natural polymers have been used less frequently. Therefore, further study on this category of polymers is required.

Keywords:

Mycobacterium tuberculosis , Non-parenteral immunization Parenteral immunization Polymeric particles Vaccine

Authors

Farzad Khademi

Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran

Mohammad Derakhshan

Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Arshid Yousefi-Avarvand

Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Mohsen Tafaghodi

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Mycobacterium tuberculosis HspX/EsxS Fusion Protein: Gene Cloning, Protein Expression, and Purification in Escherichia coli [مقاله ژورنالی]
  • ۲.Khademi F, Yousefi-Avarvand A, Derakhshan M, Vaez H, Sadeghi R. ...
  • ۳.Karimi SM, Sankian M, Khademi F, Tafaghodi M. Chitosan (CHT) ...
  • ۴.Khademi F, Derakhshan M, Sadeghi R. The role of Toll-Like ...
  • ۵.Da Costa C, Walker B, Bonavia A. Tuberculosis Vaccines–state of ...
  • ۶.Islam MA, Firdous J, Choi Y-J, Yun C-H, Cho C-S. ...
  • ۷.Reddy ST, Swartz MA, Hubbell JA. Targeting dendritic cells with ...
  • ۸.Garg NK, Dwivedi P, Jain A, Tyagi S, Sahu T, ...
  • ۹.Tafaghodi M, Sajadi Tabassi S, Jaafari MR. Nasal Immunization by ...
  • ۱۰.Tafaghodi M, Khamesipour A, Jaafari MR. Immunization against leishmaniasis by ...
  • ۱۱.Mohaghegh M, Tafaghodi M. Dextran microspheres could enhance immune responses ...
  • ۱۲.Muhamad۱۲ II, Selvakumaran S, Lazim NAM. Designing Polymeric Nanoparticles for ...
  • ۱۳.Tafaghodi M, Rastegar S. Preparation and in vivo study of ...
  • ۱۴.Wang S, Liu H, Zhang X, Qian F. Intranasal and ...
  • ۱۵.Renegar KB, Small PA, Boykins LG, Wright PF. Role of ...
  • ۱۶.Yuk J-M, Jo E-K. Host immune responses to mycobacterial antigens ...
  • ۱۷.Abebe F, Bjune G. The protective role of antibody responses ...
  • ۱۸.Khader SA, Gaffen SL, Kolls JK. Th۱۷ cells at the ...
  • ۱۹.De Valliere S, Abate G, Blazevic A, Heuertz R, Hoft ...
  • ۲۰.Tafaghodi M, Tabassi SAS, Jaafari M-R, Zakavi SR, Momennejad M. ...
  • ۲۱.Rose F, Wern JE, Ingvarsson PT, van de Weert M, ...
  • ۲۲.Carlétti D, da Fonseca DM, Gembre AF, Masson AP, Campos ...
  • ۲۳.Shi S, Hickey AJ. PLGA microparticles in respirable sizes enhance ...
  • ۲۴.Bivas-Benita M, Lin MY, Bal SM, van Meijgaarden KE, Franken ...
  • ۲۵.Kirby DJ, Rosenkrands I, Agger EM, Andersen P, Coombes AG, ...
  • ۲۶.de Paula L, Silva CL, Carlos D, Matias-Peres C, Sorgi ...
  • ۲۷.Lu D, Garcia-Contreras L, Xu D, Kurtz SL, Liu J, ...
  • ۲۸.Ha S-J, Park S-H, Kim H-J, Kim S-C, Kang H-J, ...
  • ۲۹.Cai H, Hu X, Yu D, Li S, Tian X, ...
  • ۳۰.Evans JT, Ward JR, Kern J, Johnson ME. A single ...
  • ۳۱.Lima K, Santos S, Lima V, Coelho-Castelo A, Rodrigues J, ...
  • ۳۲.Lima VM, Bonato VL, Lima KM, Dos Santos SA, Dos ...
  • ۳۳.Dhiman N, Khuller G. Protective efficacy of mycobacterial ۷۱-kDa cell ...
  • ۳۴.Carpenter ZK, Williamson ED, Eyles JE. Mucosal delivery of microparticle ...
  • ۳۵.Venkataprasad N, Coombes A, Singh M, Rohde M, Wilkinson K, ...
  • ۳۶.Todoroff J, Ucakar B, Inglese M, Vandermarliere S, Fillee C, ...
  • ۳۷.Orr MT, Kramer RM, Barnes L, Dowling QM, Desbien AL, ...
  • ۳۸.Yeboah KG, D'souza MJ. Evaluation of albumin microspheres as oral ...
  • ۳۹.Meerak J, Wanichwecharungruang SP, Palaga T. Enhancement of immune response ...
  • ۴۰.Feng G, Jiang Q, Xia M, Lu Y, Qiu W, ...
  • ۴۱.Ai W, Yue Y, Xiong S, Xu W. Enhanced protection ...
  • ۴۲.Verma A, Pandey R, Chanchal A, Siddiqui I, Sharma P. ...
  • ۴۳.Caetano LA, Figueiredo L, Almeida AJ, Gonçalves L, editors. Alginate-chitosan ...
  • ۴۴.dong Zhu B, qing Qie Y, ling Wang J, Zhang ...
  • ۴۵.Bivas-Benita M, van Meijgaarden KE, Franken KL, Junginger HE, Borchard ...
  • ۴۶.Dobakhti F, Naghibi T, Taghikhani M, Ajdary S, Rafinejad A, ...
  • ۴۷.Ajdary S, Dobakhti F, Taghikhani M, Riazi-Rad F, Rafiei S, ...
  • ۴۸.Dobakhti F, Ajdary S, Taghikhani M, Rafiei S, Bayati K, ...
  • ۴۹.Wilkinson KA, Belisle JT, Mincek M, Wilkinson RJ, Toossi Z. ...
  • ۵۰.Yu F, Wang J, Dou J, Yang H, He X, ...
  • ۵۱.Ballester M, Nembrini C, Dhar N, De Titta A, De ...
  • ۵۲.Andersen P. Vaccine strategies against latent tuberculosis infection. Trends Microbiol ...
  • ۵۳.Principi N, Esposito S. The present and future of tuberculosis ...
  • ۵۴.Wedlock D, Keen D, McCarthy A, Andersen P, Buddle B. ...
  • ۵۵.Jensen DK, Jensen LB, Koocheki S, Bengtson L, Cun D, ...
  • ۵۶.McHugh KJ, Guarecuco R, Langer R, Jaklenec A. Single-injection vaccines: ...
  • نمایش کامل مراجع